Neuralink
Founded in 2016, based in Fremont, CA, it employs around 250 people. It operates in HealthTech, Therapeutic Devices, Neurologial Diagnostics and Artificial Intelligence.
What is Neuralink?
Neuralink is a neurotechnology company co-founded by Elon Musk in 2016. Its primary aim is to develop implantable brain–machine interfaces (BMIs), which are devices that establish direct communication between the brain and external devices.
Key Objectives
Medical Applications
Treat neurological conditions such as Parkinson's disease, epilepsy, and paralysis.
Restore sensory or motor function for individuals with disabilities.
Address mental health conditions, such as depression and anxiety.
Human Enhancement
Enable humans to merge with artificial intelligence (AI) by integrating neural implants, potentially improving cognitive abilities.
Facilitate advanced human–computer interaction, like controlling devices through thoughts.
Long-Term Vision
Allow seamless brain–computer communication to enhance memory, learning, and overall neural efficiency.
Create symbiosis between humans and AI to ensure humanity's relevance in an AI-dominated future.
Core Technology
Neural Implants: Small, flexible threads equipped with electrodes inserted into the brain using a custom-built robotic system.
BCI Chip: A microchip that processes and transmits brain signals to external devices via Bluetooth or other wireless technologies.
Robot-Assisted Surgery: Highly precise surgical robots insert the threads into the brain, minimizing tissue damage.
Status and Challenges
Neuralink has conducted preclinical trials on animals and obtained FDA approval in 2023 to start human trials for addressing conditions like paralysis.
The company faces significant technical, ethical, and regulatory challenges, including risks of brain surgery, long-term implant viability, and concerns about privacy and misuse of brain data.
Business Development
Neuralink has spent the last four years building the first high channel count brain machine interface intended for therapeutic use in patients. Their first product, the N1 Link, is a 1024 channel device that, once implanted, is completely invisible and transmits data via a wireless connection. The first indication this device is intended is to help people with quadriplegia regain their digital freedom by allowing users to interact with their computers or phones in a high bandwidth and naturalistic way. The funds from the round will be used to take Neuralink’s first product to market and accelerate the research and development of future products. Neuralink has received approval from the FDA for human testing.
Key Investors
Funders Fund, GigaFund, Elon Musk, Valor Equity Partners and GV.
Neuralink stock
Neuralink remains a privately held company, which means its stock isn't available for public trading on major stock exchanges like the NYSE or NASDAQ. However, investors can explore investment opportunities through platforms like IPO CLUB, where they can gain access to shares in private companies like Neuralink. There's no announced plan for an IPO, keeping Neuralink's stock and financial performance away from public scrutiny.
Become a member for in-depth coverage of Neuralink
Most Recent Financing Status
Neuralink's latest significant financing round was a Series D round where they raised $280 million in August 2023, led by Peter Thiel's Founders Fund. This round increased their total funding to $680 million over several rounds. Following this, in November 2023, Neuralink discreetly secured an additional $43 million in venture capital, bringing the total for that particular Series D to $323 million.
Latest news
DEC 2024: Neuralink Update
JAN 2024: Neuralink breakthrough in brain-computer interface
Sep 2023: Neuralink raises $280 million in Series D round led by Founders Fund
Stay up-to-date with all the latest news about Neuralink stock, the IPO, and investment opportunities. By clicking here, you'll access real-time updates and in-depth analysis from market experts, empowering you to make informed decisions about your investment journey. Whether you're a seasoned investor or just getting started, our platform is tailored to provide you with all the crucial information you need to navigate the thrilling world of the stock market and IPOs. Dive in and keep your finger on the pulse of the financial markets.